A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.

It supports St. Jude Children’s Research Hospital, which is known for making large strides in eliminating childhood cancer. However, the hospital is also leading cutting-edge treatments and research ...